Barr Gets FDA Green Light For Allegra-D Amid Patent Dispute
The U.S. Food and Drug Administration has granted Barr Laboratories a final approval for a generic version of Aventis Pharmaceuticals' blockbuster allergy medicine Allegra-D, the company said....To view the full article, register now.
Already a subscriber? Click here to view full article